Skip to main content

UBS Group AG

Position in BCAB — BioAtla, Inc.

CIK 1610520 ZURICH, V8

Position in BCAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$25,672
-$34,794 QoQ
Shares Held
6,201
-98.3% QoQ
Ownership
0.372%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 21 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. BCAB ranks #415 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCAB

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,672 6,201
2026-03-31 $60,466 375,569
2025-12-31 $128,187 225,684
2025-09-30 $59,677 86,743
2025-06-30 $11,711 29,575
2025-03-31 $16,781 48,363
2024-12-31 $30,056 50,860
2024-09-30 $19,274 10,952
2024-06-30 $38,939 28,423
2024-03-31 $162,804 47,327
2023-12-31 $117,565 47,791
2023-09-30 $38,450 22,618
2023-06-30 $73,785 24,595
2022-12-31 $25,335 3,071
2022-09-30 $42,996 5,584
2021-12-31 $1,393,611 70,994
2021-09-30 $1,164,440 39,553
2021-06-30 $95,948 2,264
2021-03-31 $128,523 2,528
2020-12-31 $17,209 506